new medical systems limited Company Information
Company Number
06211226
Next Accounts
Nov 2025
Industry
Hospital activities
Specialist medical practice activities
Shareholders
specsavers eye care services ltd
Group Structure
View All
Contact
Registered Address
forum 6, parkway, solent business park, whiteley, fareham, hampshire, PO15 7PA
Website
www.newmedica.infonew medical systems limited Estimated Valuation
Pomanda estimates the enterprise value of NEW MEDICAL SYSTEMS LIMITED at £28.8m based on a Turnover of £24.5m and 1.17x industry multiple (adjusted for size and gross margin).
new medical systems limited Estimated Valuation
Pomanda estimates the enterprise value of NEW MEDICAL SYSTEMS LIMITED at £48.2m based on an EBITDA of £5.5m and a 8.78x industry multiple (adjusted for size and gross margin).
new medical systems limited Estimated Valuation
Pomanda estimates the enterprise value of NEW MEDICAL SYSTEMS LIMITED at £40.9m based on Net Assets of £15.5m and 2.63x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
New Medical Systems Limited Overview
New Medical Systems Limited is a live company located in fareham, PO15 7PA with a Companies House number of 06211226. It operates in the hospital activities sector, SIC Code 86101. Founded in April 2007, it's largest shareholder is specsavers eye care services ltd with a 100% stake. New Medical Systems Limited is a established, large sized company, Pomanda has estimated its turnover at £24.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
New Medical Systems Limited Health Check
Pomanda's financial health check has awarded New Medical Systems Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 4 areas for improvement. Company Health Check FAQs
8 Strong
0 Regular
4 Weak
Size
annual sales of £24.5m, make it larger than the average company (£2m)
£24.5m - New Medical Systems Limited
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of 36%, show it is growing at a faster rate (9%)
36% - New Medical Systems Limited
9% - Industry AVG
Production
with a gross margin of 71.4%, this company has a lower cost of product (45.5%)
71.4% - New Medical Systems Limited
45.5% - Industry AVG
Profitability
an operating margin of 21.9% make it more profitable than the average company (13%)
21.9% - New Medical Systems Limited
13% - Industry AVG
Employees
with 126 employees, this is above the industry average (25)
126 - New Medical Systems Limited
25 - Industry AVG
Pay Structure
on an average salary of £72.2k, the company has a higher pay structure (£31.7k)
£72.2k - New Medical Systems Limited
£31.7k - Industry AVG
Efficiency
resulting in sales per employee of £194.8k, this is more efficient (£73.7k)
£194.8k - New Medical Systems Limited
£73.7k - Industry AVG
Debtor Days
it gets paid by customers after 276 days, this is later than average (31 days)
276 days - New Medical Systems Limited
31 days - Industry AVG
Creditor Days
its suppliers are paid after 72 days, this is slower than average (35 days)
72 days - New Medical Systems Limited
35 days - Industry AVG
Stock Days
it holds stock equivalent to 8 days, this is less than average (11 days)
8 days - New Medical Systems Limited
11 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (54 weeks)
2 weeks - New Medical Systems Limited
54 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 44.2%, this is a higher level of debt than the average (39.3%)
44.2% - New Medical Systems Limited
39.3% - Industry AVG
NEW MEDICAL SYSTEMS LIMITED financials
New Medical Systems Limited's latest turnover from February 2024 is £24.5 million and the company has net assets of £15.5 million. According to their latest financial statements, New Medical Systems Limited has 126 employees and maintains cash reserves of £559.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 24,548,815 | 22,619,384 | 16,705,143 | 9,771,882 | 16,344,594 | 14,385,532 | 13,440,458 | 7,025,641 | |||||||
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
Cost Of Sales | 7,020,966 | 8,145,238 | 8,550,374 | 5,069,247 | 8,781,173 | 6,878,214 | 8,272,697 | 4,765,618 | |||||||
Gross Profit | 17,527,849 | 14,474,146 | 8,154,769 | 4,702,635 | 7,563,421 | 7,507,318 | 5,167,761 | 2,260,023 | |||||||
Admin Expenses | 12,144,467 | 12,490,609 | 6,690,818 | 3,856,857 | 6,160,967 | 6,436,551 | 4,207,973 | 2,663,599 | |||||||
Operating Profit | 5,383,382 | 1,983,537 | 1,463,951 | 845,778 | 1,402,454 | 1,070,767 | 959,788 | -403,576 | |||||||
Interest Payable | 2,214 | 600 | 0 | 410 | 2,310 | 6,917 | 64,855 | 15,895 | |||||||
Interest Receivable | 409 | 174 | 10,003 | 982 | 0 | 0 | 0 | 0 | |||||||
Pre-Tax Profit | 6,353,581 | 2,847,331 | 2,396,522 | 1,059,263 | 1,705,808 | 1,274,973 | 894,933 | -419,471 | |||||||
Tax | -82,310 | -370,483 | -262,228 | -158,291 | -271,204 | -221,589 | -87,999 | -26,356 | |||||||
Profit After Tax | 6,271,271 | 2,476,848 | 2,134,294 | 900,972 | 1,434,604 | 1,053,384 | 806,934 | -445,827 | |||||||
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
Retained Profit | 6,271,271 | 2,476,848 | 2,134,294 | 900,972 | 1,434,604 | 1,053,384 | 806,934 | -445,827 | |||||||
Employee Costs | 9,099,138 | 5,275,734 | 4,409,829 | 3,405,301 | 5,057,722 | 4,207,935 | 3,353,819 | ||||||||
Number Of Employees | 126 | 93 | 85 | 84 | 138 | 120 | 94 | 110 | 86 | ||||||
EBITDA* | 5,487,197 | 2,134,618 | 1,730,862 | 1,215,362 | 1,751,176 | 1,366,691 | 1,236,593 | -239,741 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 505,344 | 191,628 | 294,189 | 472,425 | 791,129 | 700,926 | 880,463 | 458,134 | 392,134 | 346,839 | 304,376 | 292,236 | 165,869 | 189,313 | 153,959 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 481,575 | 988 | 589 | 457 | 408 | 357 | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 986,919 | 192,616 | 294,778 | 472,882 | 791,537 | 701,283 | 880,645 | 458,134 | 392,134 | 346,839 | 304,376 | 292,236 | 165,869 | 189,313 | 153,959 |
Stock & work in progress | 158,738 | 114,769 | 197,150 | 179,287 | 155,210 | 114,227 | 90,179 | 65,116 | 40,092 | 23,292 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 18,626,676 | 14,268,581 | 8,168,954 | 5,248,270 | 5,978,822 | 5,681,647 | 2,177,544 | 974,772 | 884,682 | 870,755 | 626,769 | 644,801 | 313,971 | 93,076 | 74,789 |
Group Debtors | 5,325,597 | 5,528,199 | 2,849,669 | 2,568,008 | 3,815,325 | 5,965,323 | 3,795,093 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 2,163,467 | 1,160,053 | 742,970 | 324,430 | 176,146 | 189,144 | 226,583 | 321,640 | 202,064 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 559,209 | 64,784 | 1,804,667 | 1,022,671 | 23,573 | 625,933 | 264,185 | 139,834 | 342,075 | 372,211 | 373,021 | 217,126 | 135,940 | 59,440 | 112,138 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 26,833,687 | 21,136,386 | 13,763,410 | 9,342,666 | 10,149,076 | 12,576,274 | 6,553,584 | 1,501,362 | 1,468,913 | 1,266,258 | 999,790 | 861,927 | 449,911 | 152,516 | 186,927 |
total assets | 27,820,606 | 21,329,002 | 14,058,188 | 9,815,548 | 10,940,613 | 13,277,557 | 7,434,229 | 1,959,496 | 1,861,047 | 1,613,097 | 1,304,166 | 1,154,163 | 615,780 | 341,829 | 340,886 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 1,394,734 | 557,101 | 855,853 | 237,310 | 472,804 | 202,824 | 1,476,133 | 634,569 | 656,036 | 659,778 | 497,141 | 469,150 | 246,598 | 402,694 | 171,794 |
Group/Directors Accounts | 8,316,010 | 8,300,801 | 3,505,174 | 3,290,242 | 3,503,225 | 6,844,947 | 3,200,001 | 300,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 2,715 | 2,715 | 25,739 | 66,398 | 105,372 | 127,263 | 134,371 | 50,335 | 0 | 0 | 0 | 0 |
other current liabilities | 2,565,309 | 3,223,409 | 2,926,318 | 1,635,034 | 3,209,879 | 3,885,555 | 1,392,743 | 364,962 | 250,106 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 12,276,053 | 12,081,311 | 7,287,345 | 5,165,301 | 7,188,623 | 10,959,065 | 6,135,275 | 1,404,903 | 1,033,405 | 794,149 | 547,476 | 469,150 | 246,598 | 402,694 | 171,794 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 18,586 | 82,449 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 13,698 | 16,413 | 17,519 | 21,843 | 0 | 82,617 | 136,957 | 70,165 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43,022 | 0 | 8,312 | 0 |
provisions | 20,591 | 0 | 0 | 0 | 0 | 0 | 10,936 | 31,489 | 5,133 | 0 | 0 | 0 | 0 | 0 | 13,392 |
total long term liabilities | 20,591 | 0 | 0 | 13,698 | 16,413 | 17,519 | 51,365 | 113,938 | 87,750 | 136,957 | 70,165 | 43,022 | 0 | 8,312 | 13,392 |
total liabilities | 12,296,644 | 12,081,311 | 7,287,345 | 5,178,999 | 7,205,036 | 10,976,584 | 6,186,640 | 1,518,841 | 1,121,155 | 931,106 | 617,641 | 512,172 | 246,598 | 411,006 | 185,186 |
net assets | 15,523,962 | 9,247,691 | 6,770,843 | 4,636,549 | 3,735,577 | 2,300,973 | 1,247,589 | 440,655 | 739,892 | 681,991 | 686,525 | 641,991 | 369,182 | -69,177 | 155,700 |
total shareholders funds | 15,523,962 | 9,247,691 | 6,770,843 | 4,636,549 | 3,735,577 | 2,300,973 | 1,247,589 | 440,655 | 739,892 | 681,991 | 686,525 | 641,991 | 369,182 | -69,177 | 155,700 |
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 5,383,382 | 1,983,537 | 1,463,951 | 845,778 | 1,402,454 | 1,070,767 | 959,788 | -403,576 | |||||||
Depreciation | 103,815 | 151,081 | 266,911 | 369,584 | 348,722 | 295,924 | 276,805 | 163,835 | 144,857 | 145,141 | 114,307 | 92,502 | 74,048 | 58,738 | 20,388 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | -82,310 | -370,483 | -262,228 | -158,291 | -271,204 | -221,589 | -87,999 | -26,356 | |||||||
Stock | 43,969 | -82,381 | 17,863 | 24,077 | 40,983 | 24,048 | 25,063 | 25,024 | 16,800 | 23,292 | 0 | 0 | 0 | 0 | 0 |
Debtors | 5,158,907 | 9,195,240 | 3,620,885 | -1,829,585 | -1,865,821 | 5,636,894 | 4,902,808 | 209,666 | 215,991 | 243,986 | -18,032 | 330,830 | 220,895 | 18,287 | 74,789 |
Creditors | 837,633 | -298,752 | 618,543 | -235,494 | 269,980 | -1,273,309 | 841,564 | -21,467 | -3,742 | 162,637 | 27,991 | 222,552 | -156,096 | 230,900 | 171,794 |
Accruals and Deferred Income | -658,100 | 297,091 | 1,291,284 | -1,574,845 | -675,676 | 2,492,812 | 1,027,781 | 114,856 | 250,106 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 20,591 | 0 | 0 | 0 | 0 | -10,936 | -20,553 | 26,356 | 5,133 | 0 | 0 | 0 | 0 | -13,392 | 13,392 |
Cash flow from operations | 402,135 | -7,350,385 | -260,287 | 1,052,240 | 2,899,114 | -3,307,273 | -1,930,485 | -381,042 | |||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 480,587 | 399 | 132 | 49 | 51 | 175 | 182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 15,209 | 4,795,627 | 214,932 | -212,983 | -3,341,722 | 3,644,946 | 2,900,001 | 300,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | -18,586 | -63,863 | 82,449 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | -16,413 | -2,715 | -24,130 | -44,983 | -17,131 | -104,508 | -61,448 | 150,828 | 120,500 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43,022 | 43,022 | -8,312 | 8,312 | 0 |
share issue | |||||||||||||||
interest | -1,805 | -426 | 10,003 | 572 | -2,310 | -6,917 | -64,855 | -15,895 | |||||||
cash flow from financing | 18,404 | 4,795,201 | 208,522 | -215,126 | -3,368,162 | 3,574,460 | 2,754,152 | 408,636 | |||||||
cash and cash equivalents | |||||||||||||||
cash | 494,425 | -1,739,883 | 781,996 | 999,098 | -602,360 | 361,748 | 124,351 | -202,241 | -30,136 | -810 | 155,895 | 81,186 | 76,500 | -52,698 | 112,138 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 494,425 | -1,739,883 | 781,996 | 999,098 | -602,360 | 361,748 | 124,351 | -202,241 | -30,136 | -810 | 155,895 | 81,186 | 76,500 | -52,698 | 112,138 |
new medical systems limited Credit Report and Business Information
New Medical Systems Limited Competitor Analysis
Perform a competitor analysis for new medical systems limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in PO15 area or any other competitors across 12 key performance metrics.
new medical systems limited Ownership
NEW MEDICAL SYSTEMS LIMITED group structure
New Medical Systems Limited has 38 subsidiary companies.
Ultimate parent company
SPECSAVERS INTERNATIONAL HEALTHCARE LTD
#0029657
2 parents
NEW MEDICAL SYSTEMS LIMITED
06211226
38 subsidiaries
new medical systems limited directors
New Medical Systems Limited currently has 7 directors. The longest serving directors include Mr Giles Edmonds (Nov 2016) and Mr Douglas Perkins (Nov 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Giles Edmonds | England | 52 years | Nov 2016 | - | Director |
Mr Douglas Perkins | Guernsey | 81 years | Nov 2016 | - | Director |
Ms Rebecca Lythe | England | 53 years | Jan 2021 | - | Director |
Mr James Kirkpatrick | England | 62 years | Aug 2021 | - | Director |
Darshak Shah | England | 51 years | Feb 2022 | - | Director |
Mr Nigel Parker | Guernsey | 57 years | Jun 2024 | - | Director |
Ms Caroline Hudson | England | 56 years | Jun 2024 | - | Director |
P&L
February 2024turnover
24.5m
+9%
operating profit
5.4m
+171%
gross margin
71.4%
+11.58%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
15.5m
+0.68%
total assets
27.8m
+0.3%
cash
559.2k
+7.63%
net assets
Total assets minus all liabilities
new medical systems limited company details
company number
06211226
Type
Private limited with Share Capital
industry
86101 - Hospital activities
86220 - Specialist medical practice activities
incorporation date
April 2007
age
18
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
February 2024
previous names
charco 9 limited (September 2007)
accountant
-
auditor
-
address
forum 6, parkway, solent business park, whiteley, fareham, hampshire, PO15 7PA
Bank
-
Legal Advisor
-
new medical systems limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to new medical systems limited.
new medical systems limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NEW MEDICAL SYSTEMS LIMITED. This can take several minutes, an email will notify you when this has completed.
new medical systems limited Companies House Filings - See Documents
date | description | view/download |
---|